1
|
Daher R, Ducrot N, Lefebvre T, Zineeddine S, Ausseil J, Puy H, Karim Z. Crosstalk between Acidosis and Iron Metabolism: Data from In Vivo Studies. Metabolites 2022; 12:metabo12020089. [PMID: 35208164 PMCID: PMC8874512 DOI: 10.3390/metabo12020089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Revised: 01/05/2022] [Accepted: 01/12/2022] [Indexed: 01/27/2023] Open
Abstract
Iron absorption requires an acidic environment that is generated by the activity of the proton pump gastric H(+)/K(+)ATPase (ATP4), expressed in gastric parietal cells. However, hepcidin, the iron regulatory peptide that inhibits iron absorption, unexpectedly upregulates ATP4 and increases gastric acidity. Thus, a concept of link between acidosis and alterations in iron metabolism, needs to be explored. We investigated this aspect in-vivo using experimental models of NH4Cl-induced acidosis and of an iron-rich diet. Under acidosis, gastric ATP4 was augmented. Serum hepcidin was induced and its mRNA level was increased in the liver but not in the stomach, a tissue where hepcidin is also expressed. mRNA and protein levels of intestinal DMT1(Divalent Metal Transporter 1) and ferroportin were downregulated. Serum iron level and transferrin saturation remained unchanged, but serum ferritin was significantly increased. Under iron-rich diet, the protein expression of ATP4A was increased and serum, hepatic and gastric hepcidin were all induced. Taken together, these results provide evidence of in-vivo relationship between iron metabolism and acidosis. For clinical importance, we speculate that metabolic acidosis may contribute in part to the pathologic elevation of serum hepcidin levels seen in patients with chronic kidney disease. The regulation of ATP4 by iron metabolism may also be of interest for patients with hemochromatosis.
Collapse
Affiliation(s)
- Raêd Daher
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
| | - Nicolas Ducrot
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
| | - Thibaud Lefebvre
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
- Centre Français des Porphyries, Hôpital Louis Mourier, APHP, Nord-Université de Paris, F-75014 Colombes, France
| | - Sofia Zineeddine
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
- Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, INSERM, CNRS, F-31024 Toulouse, France;
| | - Jérome Ausseil
- Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, INSERM, CNRS, F-31024 Toulouse, France;
| | - Hervé Puy
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
- Centre Français des Porphyries, Hôpital Louis Mourier, APHP, Nord-Université de Paris, F-75014 Colombes, France
| | - Zoubida Karim
- Centre de Recherche sur l’Inflammation (CRI), Université de Paris, INSERM, CNRS, F-75018 Paris, France; (R.D.); (N.D.); (T.L.); (S.Z.); (H.P.)
- Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, INSERM, CNRS, F-31024 Toulouse, France;
- Correspondence:
| |
Collapse
|
2
|
A Literature-Based Update on Benincasa hispida (Thunb.) Cogn.: Traditional Uses, Nutraceutical, and Phytopharmacological Profiles. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2021; 2021:6349041. [PMID: 34925698 PMCID: PMC8683187 DOI: 10.1155/2021/6349041] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 06/29/2021] [Accepted: 09/20/2021] [Indexed: 12/18/2022]
Abstract
Benincasa hispida (Thunb.) Cogn. (Cucurbitaceae) is an annual climbing plant, native to Asia with multiple therapeutic uses in traditional medicine. This updated review is aimed at discussing the ethnopharmacological, phytochemical, pharmacological properties, and molecular mechanisms highlighted in preclinical experimental studies and toxicological safety to evaluate the therapeutic potential of this genus. The literature from PubMed, Google Scholar, Elsevier, Springer, Science Direct, and database was analyzed using the basic keyword “Benincasa hispida.” Other searching strategies, including online resources, books, and journals, were used. The taxonomy of the plant has been made by consulting “The Plant List”. The results showed that B. hispida has been used in traditional medicine to treat neurological diseases, kidney disease, fever, and cough accompanied by thick mucus and to fight intestinal worms. The main bioactive compounds contained in Benincasa hispida have cytotoxic, anti-inflammatory, and anticancer properties. Further safety and efficacy investigations are needed to confirm these beneficial therapeutic effects and also future human clinical studies.
Collapse
|
3
|
Zhang R, Guo Q, Kennelly EJ, Long C, Chai X. Diverse alkaloids and biological activities of Fumaria (Papaveraceae): An ethnomedicinal group. Fitoterapia 2020; 146:104697. [PMID: 32739338 DOI: 10.1016/j.fitote.2020.104697] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 07/22/2020] [Accepted: 07/28/2020] [Indexed: 01/26/2023]
Abstract
Fumaria species, commonly known as fumitory or earth smoke, are considered weeds in many regions. However, several Fumaria species have long been used in folk medicine, such as F. capreolata L., F. densiflora DC., F. indica (Hausskn.) Pugsley, F. officinalis L., F. parviflora Lam., and F. vaillantii Loisel. as well. The ethnobotany, phytochemistry, and pharmacology of 24 Fumaria species have been investigated. Phytochemical studies on Fumaria species revealed the presence of numerous alkaloids, flavonoids, saponins, and terpenoids. Phthalideisoquinolines (PTIs), protoberberines, and spirobenzylisoquinolines (SBIs) are the major alkaloids in the genus Fumaria. The plants biosynthesize a diverse group of biologically active isoquinoline alkaloids, and these may help to explain the use of various Fumaria species in folk medicine. Pharmacological studies revealed a broad spectrum of bioactivities such as hepatoprotective, anti-inflammatory, antimicrobial, antioxidant, and antitumor activities. We found 159 articles published from 1969-2019 by searching the keyword "Fumaria" using databases such as SciFinder, Google Scholar, and PubMed. Based on our reading of these papers, Fumaria species appear to be a source of bioactive isoquinoline alkaloids and ethnomedicines. The lack of studies on pharmacological mechanisms, pharmacokinetics, clinical efficacy, quality control, and toxicology are discussed in this review. There is great potential for broader medicinal applications of this genus.
Collapse
Affiliation(s)
- Ruifei Zhang
- College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China; Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Qiang Guo
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
| | - Edward J Kennelly
- College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China; Department of Biological Sciences, Lehman College, City University of New York, Bronx, NY 10468, USA; PhD Program in Biology, Biochemistry, and Chemistry, The Graduate Center, City University of New York, NY 10016, USA.
| | - Chunlin Long
- College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China; Key Laboratory of Ethnomedicine (Minzu University of China), Ministry of Education, Beijing 100081, China.
| | - Xingyun Chai
- Modern Research Center for Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
| |
Collapse
|
4
|
Craig JM. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet Med Sci 2016; 2:95-105. [PMID: 29067183 PMCID: PMC5645856 DOI: 10.1002/vms3.24] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 12/14/2015] [Accepted: 12/27/2015] [Indexed: 12/14/2022] Open
Abstract
The prevalence of human and canine allergic diseases is commonly perceived to be increasing. Suggested predisposing factors in people and dogs include increased allergen load, increased exposure to pollutants, reduced family size, reduced microbial load and less exposure to infection at a young age, increasingly urbanised environment, and changes in dietary habits. Genetic make‐up may provide a template for phenotypic predisposition which is strongly influenced by our diet and environment leading to constant regulation of gene expression. One way in which diet can alter gene expression is via its effects on the gut flora or microbiota, the collection of microbes residing in the gastrointestinal tract. The resident microbiota is important in maintaining structural and functional integrity of the gut and in immune system regulation. It is an important driver of host immunity, helps protect against invading enteropathogens, and provides nutritional benefits to the host. Disruption of the microbiota (dysbiosis) may lead to severe health problems, both in the gastrointestinal tract and extra‐intestinal organ systems. The precise mechanisms by which the intestinal microbiota exerts its effects are only beginning to be unravelled but research is demonstrating close links between gut microflora and many factors involved in the pathogenesis of atopic dermatitis (AD). AD and indeed any other ‘skin disease’, may be seen as a possible manifestation of a more systemic problem involving gut dysbiosis and increased intestinal permeability, which may occur even in the absence of gastrointestinal signs. Manipulation of the canine intestinal microbiota as a method for modifying atopy, may be attempted in many ways including avoidance of certain foods, supplementation with probiotics and prebiotics, optimising nutrient intake, minimising stress, antimicrobial therapy, correction and prevention of low stomach acid, and faecal microbiota transplantation (FMT).
Collapse
|